R&D Strength Actafarma emphasizes strong investment in research and development with collaborations across public institutions and universities, suggesting opportunities to position high-quality, clinically supported nutritional and pharmaceutical products to procurement teams and public health partners.

Clinical Validation The company highlights a nutraceutical with clinical safety studies and a year-long human trial, signaling credibility to buyers seeking evidence-based supplements for prestige channels, hospitals, and specialty clinics.

Global Expansion An extensive product pipeline and history of expanding to Europe and the Americas indicate receptivity to distribution partnerships, co-branding deals, and regional regulatory navigation with potential new markets.

Portfolio Synergy A diversified catalog across longevity, joints, metabolism, and beauty creates cross-sell opportunities with existing customers and channel partners looking for complementary health solutions.

SME Agility With a mid-size employee base (51-200) and a modern tech stack, Actafarma can be a nimble partner capable of rapid collaboration on private-label programs, contract manufacturing, or joint product launches.